No Data
No Data
Domestic Innovative Drugs are once again surging towards overseas markets! Concept stocks have responded with a significant increase. Is the external authorization model the optimal choice?
① As of the time of publication, the Hang Seng Innovative Drugs Index has risen over 5%, with multiple Innovative Drugs concept stocks experiencing double-digit gains; ② In recent days, Jiangsu Hengrui Pharmaceuticals, Hepo Pharmaceutical, UNITED LAB, and other Biotech companies have issued announcements about "going abroad"; ③ Northeast Securities stated that top MNCs recognize the R&D capabilities of Chinese local companies and are more willing to assign high valuations.
HK stocks move | CRO Concept stocks' gains widen, WUXI BIO (02269) rises over 6%. The Industry leader's revenue and profit have stabilized and rebounded in the fourth quarter.
The gains of CRO Concept stocks have expanded. As of the time of writing, VIVA BIOTECH (01873) is up 6.19%, priced at 2.06 Hong Kong dollars; WUXI BIO (02269) is up 5.92%, priced at 27.75 Hong Kong dollars; Joinn Laboratories (06127) is up 5.3%, priced at 15.9 Hong Kong dollars; WUXI APPTEC (02359) is up 5.46%, priced at 70.55 Hong Kong dollars; PHARMARON (03759) is up 5.16%, priced at 16.72 Hong Kong dollars.
The Hong Kong stock market's CXO Sector collectively strengthened, with WUXI APPTEC rising over 4%.
Gelonghui, March 27 | VIVA BIOTECH rose over 7%, Joinn Laboratories and WUXI BIO rose over 6%, PHARMARON and WUXI APPTEC rose over 4%, TIGERMED and Asymchem Laboratories rose over 3%, GENSCRIPT BIO rose over 2%.
Hong Kong Stock Market Midday Review | All three major indices rose, the Tech Index increased by over 1%; technology and semiconductor stocks were active, Bilibili rose over 4%, Semiconductor Manufacturing International Corporation rose over 6%.
Most Network Technology stocks rose, with SenseTime-W down 6.29% and Bilibili-W up 4.62%; Pharmaceutical stocks rose, with INNOVENT BIO up 14.08% and 3SBIO up 10.91%; Biotechnology stocks generally rose, with ASCENTAGE-B up 8.70% and WUXI XDC up 7.04%.
S&P Global Market Intelligence has listed the top ten shorted Hong Kong stocks recently.
S&P Global Market Intelligence has listed the top ten most shorted stocks in Hong Kong as of Monday (March 24). The data is calculated based on the securities financing dataset from S&P Global Market Intelligence. The indicators for calculating short selling (short ratio) represent the percentage of borrowed shares relative to the total outstanding shares. Stock Name │ Number of Borrowed Shares (millions) │ Change in the Past 7 Days % │ Short Ratio % │ Price Change in the Past 7 Days % Vanke (02202.HK) │ 354.54 │ -0.28% │ 16.07% │ -6.53% GANFENGLITHIUM (01772.HK) │ 55.27 │ -0.06%
WUXI APPTEC (603259.SH, 02359) remains unyielding against adversity, crossing cycles for steady growth, a victory of resilient genes and long-termism.
In 2024, WUXI APPTEC achieved its performance guidance set at the beginning of the year. In 2025, under the dual narrative of "steady growth + shareholder returns," WUXI APPTEC is even more值得期待.